相似文献
1
Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
J Clin Microbiol. 2013 Jan;51(1):311-3. doi: 10.1128/JCM.02735-12. Epub 2012 Nov 7.
2
Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm.
Br J Biomed Sci. 2009;66(4):175-9. doi: 10.1080/09674845.2009.11730269.
3
Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.00555-18. Print 2018 Dec.
4
Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
J Clin Microbiol. 2010 Jan;48(1):124-30. doi: 10.1128/JCM.00734-09. Epub 2009 Nov 18.
5
Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
J Clin Microbiol. 2014 Jan;52(1):275-80. doi: 10.1128/JCM.02545-13. Epub 2013 Nov 13.
6
Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
J Clin Microbiol. 2010 Mar;48(3):889-93. doi: 10.1128/JCM.01801-09. Epub 2010 Jan 13.
7
Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01872-19.
8
High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
J Clin Microbiol. 2018 May 25;56(6). doi: 10.1128/JCM.00170-18. Print 2018 Jun.
9
Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.
Ann Lab Med. 2014 May;34(3):235-9. doi: 10.3343/alm.2014.34.3.235. Epub 2014 Apr 8.
10
Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3295-9. doi: 10.1007/s10096-012-1695-6. Epub 2012 Jul 20.
引用本文的文献
1
Diagnostic Guidance for C. difficile Infections.
Adv Exp Med Biol. 2024;1435:33-56. doi: 10.1007/978-3-031-42108-2_3.
2
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection.
Eur J Clin Microbiol Infect Dis. 2024 Feb;43(2):313-324. doi: 10.1007/s10096-023-04729-z. Epub 2023 Dec 11.
3
Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study.
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2423-2430. doi: 10.1007/s10096-017-3080-y. Epub 2017 Aug 12.
4
Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.
Infect Dis (Lond). 2016 Sep;48(9):663-9. doi: 10.1080/23744235.2016.1186832. Epub 2016 May 20.
5
Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection.
Genome Med. 2016 Apr 27;8(1):47. doi: 10.1186/s13073-016-0298-8.
6
Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.
J Antimicrob Chemother. 2016 Apr;71(4):975-85. doi: 10.1093/jac/dkv452. Epub 2016 Jan 11.
7
Quantitative Fecal Lactoferrin as a Biomarker for Severe Infection in Hospitalized Patients.
J Geriatr Palliat Care. 2014;2(1):3. doi: 10.13188/2373-1133.1000006.
8
Antimicrobial proteins in intestine and inflammatory bowel diseases.
Intest Res. 2014 Jan;12(1):20-33. doi: 10.5217/ir.2014.12.1.20. Epub 2014 Jan 28.
9
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.
PLoS One. 2014 Aug 29;9(8):e106118. doi: 10.1371/journal.pone.0106118. eCollection 2014.
10
Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):1045-51. doi: 10.1007/s10096-013-2043-1. Epub 2014 Jan 22.
本文引用的文献
1
Outcomes in patients tested for Clostridium difficile toxins.
Diagn Microbiol Infect Dis. 2012 Dec;74(4):369-73. doi: 10.1016/j.diagmicrobio.2012.08.019. Epub 2012 Sep 23.
2
Clostridium difficile detection: identification of colonization, subclinical and overt disease.
J Hosp Infect. 2012 Oct;82(2):138-9. doi: 10.1016/j.jhin.2012.07.015. Epub 2012 Aug 27.
3
Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
Diagn Microbiol Infect Dis. 2012 May;73(1):94-6. doi: 10.1016/j.diagmicrobio.2012.01.005. Epub 2012 Mar 15.
4
The role of toxin A and toxin B in the virulence of Clostridium difficile.
Trends Microbiol. 2012 Jan;20(1):21-9. doi: 10.1016/j.tim.2011.11.003. Epub 2011 Dec 7.
5
A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA?
J Hosp Infect. 2012 Jan;80(1):82-4. doi: 10.1016/j.jhin.2011.09.012. Epub 2011 Nov 21.
6
Host and pathogen factors for Clostridium difficile infection and colonization.
N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.
7
Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB.
J Clin Microbiol. 2011 Nov;49(11):3788-93. doi: 10.1128/JCM.00679-11. Epub 2011 Aug 31.
8
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?
J Mol Diagn. 2011 Nov;13(6):573-82. doi: 10.1016/j.jmoldx.2011.06.001. Epub 2011 Aug 18.
9
Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both?
J Hosp Infect. 2011 Sep;79(1):1-3. doi: 10.1016/j.jhin.2011.05.010. Epub 2011 Jul 19.
10
Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
Clin Infect Dis. 2011 Aug 1;53(3):287-90. doi: 10.1093/cid/cir361.
Zotero 插件